article thumbnail

Stelara for psoriasis: Dosage, efficacy & more

The Checkup by Singlecare

The subcutaneous dosage of Stelara for psoriasis is as follows: For adults with psoriasis who weigh 220 pounds or less: The first dose is 45 mg. The dosage for pediatric patients (6 to 17 years of age) is based on weight. Stelara as a treatment for psoriasis People with psoriasis have an overactive immune system. every eight weeks.

Dosage 98
article thumbnail

Drug Formulation In-Depth Focus 2022

European Pharmaceutical Review

Cyclodextrins are a frequently used excipient in the pharmaceutical industry, employed in multiple dosage forms and with multiple purposes simply because of their numerous positive properties, including being generally well tolerated and safe. The post Drug Formulation In-Depth Focus 2022 appeared first on European Pharmaceutical Review.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The best SingleCare reviews of 2022

The Checkup by Singlecare

Whether your goal is to lose weight, build muscle , or manage conditions like insulin resistance or Type 2 diabetes , SingleCare’s blog, The Checkup , has plenty of health and wellness articles to ensure you have a happy and healthy 2023. Search for your medication and adjust for location, dosage, and quantity. visit our Help page.

Dosage 98
article thumbnail

Farxiga for heart failure: How it works, effectiveness & more

The Checkup by Singlecare

In 2022, another trial was published in NEJM. Farxiga dosages for heart failure Before taking Farxiga, your healthcare provider will check your kidney function and volume status. The dosage of Farxiga is based on the estimated glomerular filtration rate (eGFR), a measure of kidney function.

article thumbnail

Antimicrobial Stewardship in Turkey – A Clinical Pharmacist’s Perspective

IDStewardship

In this article, a pharmacist from Turkey with advanced training in the area of infectious diseases provides insights on antimicrobial stewardship in Turkey. BCPS, BCIDP Article Posted 1 August 2023 A man colonized with extensively drug resistant Acinetobacter baumannii gets on a plane. Interview with: Emre Kara, MSc.,

Hospitals 212
article thumbnail

Empagliflozin recommended by NICE for use in chronic heart failure

Hospital Pharmacy Europe

The European Commission granted marketing authorisation for empagliflozin as a treatment for adults with symptomatic chronic heart failure in March 2022. This should include taking into account the administration costs, dosage, price per dose and commercial arrangements, NICE said.

Dosage 52
article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

This is the practice of modifying the product, ie, changing the dosing interval from three times daily (tid) to once daily (od) using controlled release dosage forms immediately prior to generic entry into the market – but equally it could be argued also improving patient compliance. Cited 25 September 2022]. Cited 25 September 2022].

FDA 75